Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Nov
9
2023
IP 101 for Emerging Healthy F&B Companies Foley & Lardner LLP
Nov
9
2023
FDA Moves to End Use of Brominated Vegetable Oil in Food Sheppard, Mullin, Richter & Hampton LLP
Nov
9
2023
This Will Be Our Year, Took a Long Time to Come: Will 2024 Be the Year for Marijuana Legalization in North Carolina? Bradley Arant Boult Cummings LLP
Nov
9
2023
This Week in 340B: October 31 – November 5, 2023 McDermott Will & Emery
Nov
8
2023
OIG General Compliance Program Guidance November 2023 Sheppard, Mullin, Richter & Hampton LLP
Nov
8
2023
Ohio Legalizes Recreational Marijuana, But Employers’ Ability to Enforce Workplace Drug Policies Remains Intact (US) Squire Patton Boggs (US) LLP
Nov
8
2023
Ohio Votes for the Decriminalization of Marijuana Dinsmore & Shohl LLP
Nov
8
2023
Rocky Top Update – A Summary of the Tennessee Medical Cannabis Commission’s October Meeting Bradley Arant Boult Cummings LLP
Nov
8
2023
Ohio Passes Recreational Marijuana Law: What Employers Should Know Jackson Lewis P.C.
Nov
8
2023
Plaintiff Asks Court to Revive Coors Light False Ad Suit Keller and Heckman LLP
Nov
7
2023
Massachusetts: Proceed With Caution - New Vaccination Criteria for Hospitals and Other Licensed Health Facilities Foley & Lardner LLP
Nov
7
2023
FDA Updates CFSAN Online Submission Module (COSM) Keller and Heckman LLP
Nov
6
2023
USPTO Report On COVID-19 Diagnostic Patent Filings Foley & Lardner LLP
Nov
6
2023
California’s New Employment Laws for 2024: A Roundup of New Laws Ogletree, Deakins, Nash, Smoak & Stewart, P.C.
Nov
6
2023
2023 National Youth Tobacco Survey Shows Significant Decline in High School Vaping Keller and Heckman LLP
Nov
6
2023
Second Circuit Reverses Dismissal of “Reef Friendly” Claims Keller and Heckman LLP
Nov
4
2023
Privacy Tip #378 – Bad Actors Selling Data of 23andMe Users of Ashkenazi Jewish and Chinese Descent Robinson & Cole LLP
Nov
4
2023
Hair Products with Formaldehyde Are Going Out of Style: Is Your Organization Ready for the Change? Sheppard, Mullin, Richter & Hampton LLP
Nov
3
2023
Proposed Amendments to Prop 65’s Warning Requirements Keller and Heckman LLP
Nov
3
2023
FDA LDT Webinar Serves as a Reminder to Industry to Submit Comments on the Proposed Rule Epstein Becker & Green, P.C.
Nov
3
2023
Medical Marketer Convicted of $55 Million Fraud Scheme ArentFox Schiff LLP
Nov
2
2023
FDA Proposes Rule to Prohibit Brominated Vegetable Oil in Food Keller and Heckman LLP
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Nov
1
2023
PFAS in Consumer Products: CPSC Requests Input Keller and Heckman LLP
Nov
1
2023
FDA Issued a Proposed Rule to Amend Prior Notice Regulation Keller and Heckman LLP
Nov
1
2023
PFAS Consumer Fraud Lawsuit Update: New Protein Supplement Case In NY CMBG3 Law
Oct
31
2023
FDA Seeks Comments on Revised Draft Guidance for Communicating Scientific Information on Unapproved Uses of Approved/Cleared Medical Products Keller and Heckman LLP
Oct
31
2023
The Haunting in the Cornfield: Relators’ Qui Tam Claim Confirmed Dead by the Eighth Circuit Bradley Arant Boult Cummings LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins